Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Ugel

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Cancer Immunology Research|May 4, 2021
Galectin-1 Supports a Dangerous Liaison between Monocytes and Multiple MyelomaStefano Ugel, Vincenzo Bronte
Frontiers in Oncology|August 24, 2023
Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factorsStefano Ugel, Chiara Bazzichetto, Fabiana Conciatori
Microbiology Spectrum|June 24, 2016
Tumor-Induced Myeloid-Derived Suppressor CellsFrancesco De Sanctis, Vincenzo Bronte, Stefano Ugel
Aging|December 1, 2017
Anti-telomerase T cells adoptive transferFrancesco De Sanctis, Rosalinda Trovato, Stefano Ugel
Current Opinion in Pharmacology|May 30, 2017
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDOGiada Mondanelli, Stefano Ugel, Ursula Grohmann, et al.
The Journal of Clinical Investigation|September 2, 2015
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesStefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, et al.
Seminars in Immunology|March 2, 2018
The dark side of tumor-associated endothelial cellsFrancesco De Sanctis, Stefano Ugel, John Facciponte, et al.
Annual Review of Pathology|January 26, 2021
Monocytes in the Tumor MicroenvironmentStefano Ugel, Stefania Canè, Francesco De Sanctis, et al.
Seminars in Immunopathology|September 26, 2022
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapyFrancesco De Sanctis, Annalisa Adamo, Stefania Canè, et al.
Frontiers in Genetics|June 2, 2022
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell TechnologiesSimone Caligola, Francesco De Sanctis, Stefania Canè, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Cancer Immunology Research|May 4, 2021
Galectin-1 Supports a Dangerous Liaison between Monocytes and Multiple MyelomaStefano Ugel, Vincenzo Bronte
Frontiers in Oncology|August 24, 2023
Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factorsStefano Ugel, Chiara Bazzichetto, Fabiana Conciatori
Microbiology Spectrum|June 24, 2016
Tumor-Induced Myeloid-Derived Suppressor CellsFrancesco De Sanctis, Vincenzo Bronte, Stefano Ugel
Aging|December 1, 2017
Anti-telomerase T cells adoptive transferFrancesco De Sanctis, Rosalinda Trovato, Stefano Ugel
Current Opinion in Pharmacology|May 30, 2017
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDOGiada Mondanelli, Stefano Ugel, Ursula Grohmann, et al.
The Journal of Clinical Investigation|September 2, 2015
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesStefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, et al.
Seminars in Immunology|March 2, 2018
The dark side of tumor-associated endothelial cellsFrancesco De Sanctis, Stefano Ugel, John Facciponte, et al.
Annual Review of Pathology|January 26, 2021
Monocytes in the Tumor MicroenvironmentStefano Ugel, Stefania Canè, Francesco De Sanctis, et al.
Seminars in Immunopathology|September 26, 2022
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapyFrancesco De Sanctis, Annalisa Adamo, Stefania Canè, et al.
Frontiers in Genetics|June 2, 2022
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell TechnologiesSimone Caligola, Francesco De Sanctis, Stefania Canè, et al.
Pageof 10